Skip to main content

17 March 2026

Last updated: Tuesday 17 March 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The promise of episomal reprogramming

Sunday 24 November 2013

Interviewee/Contributor

Nick Seay

Organisation

Cellular Dynamics International Inc

Organisations

NDA Regulatory Science Ltd
Sofinnova Partners Telethon Strategy
Mission Therapeutics
Merck Sharp & Dohme (Europe)
Food and Drug Administration
BC Platforms AG
Clavis Pharma ASA
Crescendo Biologics Ltd
UCB SA
Antitope Ltd

Interviewees and Contributers

Priya Kalia and Miranda Weston-Smith
Jan Fagerberg
Don Picker
Todd McAllister
Jane Robertson
Walter Schmidt
Neil Miller
Emma Dabbs
Brian Edwards
Steff Taelman

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Poolbeg Pharma names drug developer to SAB

Saturday 14 March 2026

Commit Biologics names biotech entrepreneur as CEO

Saturday 14 March 2026

Orexo changes management in strategic shift

Saturday 14 March 2026

New CFO at Beacon Therapeutics

Saturday 14 March 2026

4basebio names new COO and CCO, strengthens commercial team

Saturday 14 March 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form